Webinar: Advancing the discovery of immunotherapeutics with large scale, multiplexed experiments
May 03, 2016 : WebEx: 8:00 am- 9:00 am PST
Large scale multiplexed experiments assessing cells and proteins of the immune system are critical to understanding and advancement of immunotherapy treatment for cancer and other diseases.
This webinar will highlight:
- How current challenges in antibody screening workflows can be overcome by the iQue Screener’s ability to simultaneously screen cells and proteins in suspension
- How users of our technology have advanced their research by benefiting from fast time to results, miniaturized assays, flexibility and choice in content and multiplexing
- Key cell and bead based applications run on the iQue Screener including: evaluation of cell killing mechanism, screening for immune checkpoint inhibitors and more.
Tom Duensing, CTO, IntelliCyt Corporation.
Belen Ybarrondo, Adjunct Faculty, San Diego Community College.